Venetoclax, Cladribine, Low Dose Cytarabine, and Azacitidine in Treating Patients With Previously Untreated Acute Myeloid Leukemia

NCT03586609 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

145

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia

Interventions

DRUG: Azacitidine
DRUG: Cladribine
DRUG: Cytarabine
DRUG: Venetoclax

Sponsor

M.D. Anderson Cancer Center